142 related articles for article (PubMed ID: 33772986)
21. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
22. Butyrate promotes oral squamous cell carcinoma cells migration, invasion and epithelial-mesenchymal transition.
Zang W; Liu J; Geng F; Liu D; Zhang S; Li Y; Pan Y
PeerJ; 2022; 10():e12991. PubMed ID: 35223210
[TBL] [Abstract][Full Text] [Related]
23. Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma.
Chea C; Miyauchi M; Inubushi T; Okamoto K; Haing S; Nguyen PT; Imanaka H; Takata T
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):142-147. PubMed ID: 30415774
[TBL] [Abstract][Full Text] [Related]
24. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
25. P120ctn may participate in epithelial-mesenchymal transition in OSCC.
Zhong C; Zuo Z; Ji Q; Feng D
Indian J Cancer; 2016; 53(1):20-4. PubMed ID: 27146732
[TBL] [Abstract][Full Text] [Related]
26. LncRNA HOTAIR promotes the invasion and metastasis of oral squamous cell carcinoma through metastasis-associated gene 2.
Tao D; Zhang Z; Liu X; Zhang Z; Fu Y; Zhang P; Yuan H; Liu L; Cheng J; Jiang H
Mol Carcinog; 2020 Apr; 59(4):353-364. PubMed ID: 31995261
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA‑199a‑5p suppresses migration and invasion in oral squamous cell carcinoma through inhibiting the EMT‑related transcription factor SOX4.
Wei D; Wang W; Shen B; Zhou Y; Yang X; Lu G; Yang J; Shao Y
Int J Mol Med; 2019 Jul; 44(1):185-195. PubMed ID: 31059001
[TBL] [Abstract][Full Text] [Related]
28. Naa10p and IKKα interaction regulates EMT in oral squamous cell carcinoma via TGF-β1/Smad pathway.
Lv S; Luo T; Yang Y; Li Y; Yang J; Xu J; Zheng J; Zeng Y
J Cell Mol Med; 2021 Jul; 25(14):6760-6772. PubMed ID: 34060226
[TBL] [Abstract][Full Text] [Related]
29. Epithelial-to-mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities.
Ling Z; Cheng B; Tao X
Int J Cancer; 2021 Apr; 148(7):1548-1561. PubMed ID: 33091960
[TBL] [Abstract][Full Text] [Related]
30. Differential roles of kallikrein-related peptidase 6 in malignant transformation and ΔNp63β-mediated epithelial-mesenchymal transition of oral squamous cell carcinoma.
Kaneko N; Kawano S; Yasuda K; Hashiguchi Y; Sakamoto T; Matsubara R; Goto Y; Jinno T; Maruse Y; Morioka M; Hattori T; Tanaka S; Tanaka H; Kiyoshima T; Nakamura S
Oral Oncol; 2017 Dec; 75():148-157. PubMed ID: 29224812
[TBL] [Abstract][Full Text] [Related]
31. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.
Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT
Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255
[TBL] [Abstract][Full Text] [Related]
32. The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway.
Wang J; Jiang C; Li N; Wang F; Xu Y; Shen Z; Yang L; Li Z; He C
Cell Death Dis; 2020 Aug; 11(8):682. PubMed ID: 32826876
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
[TBL] [Abstract][Full Text] [Related]
34. CCL2 promotes cell migration by inducing epithelial-mesenchymal transition in oral squamous cell carcinoma.
Ling Z; Yang X; Chen X; Xia J; Cheng B; Tao X
J Oral Pathol Med; 2019 Jul; 48(6):477-482. PubMed ID: 31077446
[TBL] [Abstract][Full Text] [Related]
35. Arecoline induces epithelial-mesenchymal transformation and promotes metastasis of oral cancer by SAA1 expression.
Ren H; He G; Lu Z; He Q; Li S; Huang Z; Chen Z; Cao C; Wang A
Cancer Sci; 2021 Jun; 112(6):2173-2184. PubMed ID: 33626219
[TBL] [Abstract][Full Text] [Related]
36. AURKA contributes to the progression of oral squamous cell carcinoma (OSCC) through modulating epithelial-to-mesenchymal transition (EMT) and apoptosis via the regulation of ROS.
Dawei H; Honggang D; Qian W
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):83-90. PubMed ID: 30454901
[TBL] [Abstract][Full Text] [Related]
37. Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines.
Ohta M; Abe A; Ohno F; Hasegawa Y; Tanaka H; Maseki S; Kondo E; Kurita K; Nakanishi H
Oral Oncol; 2013 Jan; 49(1):20-6. PubMed ID: 22840788
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-22 promotes the migration and invasion of oral squamous cell carcinoma cells.
Komine-Aizawa S; Aizawa S; Takano C; Hayakawa S
Immunol Med; 2020 Sep; 43(3):121-129. PubMed ID: 32546118
[TBL] [Abstract][Full Text] [Related]
39. TWIST1 regulates proliferation, migration, and invasion and is a prognostic marker for oral tongue squamous cell carcinoma.
de Morais EF; de Farias Morais HG; de Moura Santos E; Barboza CAG; Téo FH; Salo T; Coletta RD; de Almeida Freitas R
J Oral Pathol Med; 2023 Feb; 52(2):127-135. PubMed ID: 36285599
[TBL] [Abstract][Full Text] [Related]
40. Sodium Phenylbutyrate Inhibits Tumor Growth and the Epithelial-Mesenchymal Transition of Oral Squamous Cell Carcinoma In Vitro and In Vivo.
Qian K; Sun L; Zhou G; Ge H; Meng Y; Li J; Li X; Fang X
Cancer Biother Radiopharm; 2018 May; 33(4):139-145. PubMed ID: 29658787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]